BSECompany Update5 Nov 2026 · 5 Nov 2026, 05:03 pm
Detailed disclosure is attached.
Gujarat Terce Laboratories Ltd · 524314
✦ AI SummaryExpansion
Gujarat Terce Laboratories Ltd has entered into an agreement to purchase a corporate office premises 'Swati18' located in Ahmedabad. The company has disclosed the details of the agreement as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Terce Laboratories Ltd - 524314 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended From Time To Time (Listing Regulations)
Attachments (1)
📄pdf
Download →
a34670c0-c913-4ad3-9edc-64eb1450dc9d.pdf
View document text
5 November 2026
BSE Limited
(Security Code: 524314)
Phiroze Jeejeeboy Towers,
Dalal Street, Fort,
Mumbai- 400 001.
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended from time to time (Listing
Regulations)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we wish to inform that the Company has entered into an agreement(s) for purchase of Corporate office
premises “Swati18” located beside Palladium Mall, S.G. Highway, Thaltej, Ahmedabad.
Further, the requisite details as prescribed under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, read with Schedule III thereto and SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed herewith as Annexure-
This intimation is also uploaded on the Company’s website and can be accessed at the weblink:
https://www.gujaratterce.in/announcements/
For Gujarat Terce Laboratories Limited
Ms. Ashka Solanki
Company Secretary
Enclosures: As above
Annexure-I
Details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026
dated January 30, 2026
Sr. No. Particulars Details
1. Name of parties with whom the agreement is Swatisandhya Procon LLP
entered
2. Purpose of entering into the agreement Purchase of immovable property (Corporate
Office premises)
3. Shareholding, if any, in the entity with whom the Nil
agreement is executed
4. Significant terms of the agreement (in brief) special Purchase of immovable property of 2012.20
rights like right to appoint directors, first right to sq.ft. at Rs. 3.23 crores (exclusive of applicable
share subscription in case of issuance of shares, taxes, stamp duty, registration fees and other
right to restrict any change in capital structure etc statutory or incidental charges payable under
the agreement to sell)
5. Whether, the said parties are related to No
promoter/promoter group/ group companies in
any manner. If yes, nature of relationship
6. Whether the transaction would fall within related No
party transactions? If yes, whether the same is
done at “arm’s length”
7. In case of issuance of shares to the parties, details No
of issue price, class of shares issued
8. Any other disclosures related to such agreements, N.A.
viz., details of nominee on the board of directors of
the listed entity, potential conflict of interest
arising out of such agreements, etc
9. In case of termination or amendment of N.A.
agreement, listed entity shall disclose additional
details to the stock exchange(s):
a) name of parties to the agreement;
b) nature of the agreement;
c) date of execution of the agreement;
d) details of amendment and impact thereof or
reasons of termination and impact thereof